MS4A2
Basic information
Region (hg38): 11:60088261-60098467
Previous symbols: [ "FCER1B", "IGER", "APY" ]
Links
Phenotypes
GenCC
Source:
- IgE responsiveness, atopic (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MS4A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 15 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 15 | 4 | 3 |
Variants in MS4A2
This is a list of pathogenic ClinVar variants found in the MS4A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-60088757-A-G | MS4A2-related disorder | Likely benign (May 23, 2019) | ||
11-60088780-T-C | MS4A2-related disorder | Benign (Mar 22, 2019) | ||
11-60089686-TCA-T | MS4A2-related disorder | Likely benign (Jun 05, 2019) | ||
11-60089693-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
11-60089708-G-T | not specified | Uncertain significance (Mar 08, 2024) | ||
11-60089727-A-C | not specified | Uncertain significance (Jun 05, 2023) | ||
11-60089736-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
11-60089757-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
11-60089806-G-A | MS4A2-related disorder | Likely benign (Jun 05, 2019) | ||
11-60089813-T-C | not specified | Uncertain significance (May 03, 2023) | ||
11-60090354-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
11-60090432-T-A | not specified | Uncertain significance (Dec 15, 2022) | ||
11-60092820-T-C | not specified | Uncertain significance (Sep 20, 2023) | ||
11-60092826-A-G | not specified | Uncertain significance (Dec 05, 2022) | ||
11-60092838-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
11-60093432-C-A | not specified | Uncertain significance (Feb 06, 2023) | ||
11-60093449-C-T | Benign (Jun 29, 2018) | |||
11-60093494-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
11-60093497-T-A | not specified | Uncertain significance (May 11, 2022) | ||
11-60093499-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
11-60093978-G-C | not specified | Uncertain significance (May 26, 2022) | ||
11-60094059-C-A | Benign (Jun 18, 2018) | |||
11-60095567-G-T | not specified | Uncertain significance (May 22, 2023) | ||
11-60095591-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
11-60095631-A-G | RECLASSIFIED - POLYMORPHISM | Benign (Sep 01, 2001) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MS4A2 | protein_coding | protein_coding | ENST00000278888 | 7 | 7711 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.60e-9 | 0.0687 | 124940 | 8 | 798 | 125746 | 0.00321 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.309 | 133 | 123 | 1.08 | 0.00000555 | 1568 |
Missense in Polyphen | 44 | 34.698 | 1.2681 | 467 | ||
Synonymous | -0.677 | 50 | 44.3 | 1.13 | 0.00000210 | 482 |
Loss of Function | -0.332 | 12 | 10.8 | 1.11 | 4.59e-7 | 140 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000416 | 0.000416 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0221 | 0.0220 |
European (Non-Finnish) | 0.00273 | 0.00273 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000100 | 0.0000980 |
Other | 0.00196 | 0.00196 |
dbNSFP
Source:
- Function
- FUNCTION: High affinity receptor that binds to the Fc region of immunoglobulins epsilon. Aggregation of FCER1 by multivalent antigens is required for the full mast cell response, including the release of preformed mediators (such as histamine) by degranulation and de novo production of lipid mediators and cytokines. Also mediates the secretion of important lymphokines. Binding of allergen to receptor-bound IgE leads to cell activation and the release of mediators responsible for the manifestations of allergy.;
- Pathway
- Fc epsilon RI signaling pathway - Homo sapiens (human);Asthma - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Fc Epsilon Receptor I Signaling in Mast Cells;fc epsilon receptor i signaling in mast cells;Fc-epsilon receptor I signaling in mast cells
(Consensus)
Recessive Scores
- pRec
- 0.152
Intolerance Scores
- loftool
- 0.793
- rvis_EVS
- 0.91
- rvis_percentile_EVS
- 89.44
Haploinsufficiency Scores
- pHI
- 0.0371
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.584
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ms4a2
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- inflammatory response;immune response;Fc-epsilon receptor signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;external side of plasma membrane;Fc-epsilon receptor I complex
- Molecular function
- IgE binding